TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33184089

Group type: EXPERIMENTAL
Intervention: TEG-guided blood product transfusion (TEG-BT)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Traditional blood product transfusion (T-BT)
Number of subjects: 162
Study: 33338737

Group type: EXPERIMENTAL
Intervention: Positive psychology-motivational interviewing (PP-MI) program, 16-week, phone-delivered
Number of subjects: 70

Group type: COMPARATOR
Intervention: Attention-matched diabetes counseling condition
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Positive psychology-motivational interviewing (PP-MI) program
Number of subjects: 70
Study: 35987681

Group type: COMPARATOR
Intervention: IVIG alone (2 gr/kg)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: IVIG + methylprednisolone (2 gr/kg + 2 mg/kg/day)
Number of subjects: 91
Study: 33482893

Group type: EXPERIMENTAL
Intervention: Adaptive servo-ventilation (ASV) treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immediate SDB treatment with ASV
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (ASV− group)
Number of subjects: 0
Study: 32197407

Group type: EXPERIMENTAL
Intervention: Carbohydrate intake at lunch (quintile 5 vs quintile 1)
Number of subjects: 5517

Group type: EXPERIMENTAL
Intervention: Carbohydrate intake at dinner
Number of subjects: 5517

Group type: EXPERIMENTAL
Intervention: High protein intake at lunch and dinner
Number of subjects: 5517

Group type: EXPERIMENTAL
Intervention: Moderate fat intake at lunch
Number of subjects: 5517

Group type: EXPERIMENTAL
Intervention: Low carbohydrate-high protein-moderate fat lunch and low carbohydrate-high protein dinner
Number of subjects: 5517
Study: 35333878

Group type: EXPERIMENTAL
Intervention: Active recruitment method
Number of subjects: 2035

Group type: COMPARATOR
Intervention: Passive recruitment method
Number of subjects: 2035

Group type: EXPERIMENTAL
Intervention: Higher BMI at baseline
Number of subjects: 2035

Group type: EXPERIMENTAL
Intervention: Older age at recruitment
Number of subjects: 2035

Group type: EXPERIMENTAL
Intervention: Weight loss of at least 2 kg in the first year
Number of subjects: 2035
Study: 34635547

Group type: EXPERIMENTAL
Intervention: GABA 600 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 6
Study: 32070401

Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg PO daily plus bevacizumab 15 mg/kg IV every 3 weeks (Let/Bev)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Letrozole 2.5 mg PO daily (Let)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Let/Bev
Number of subjects: 75

Group type: COMPARATOR
Intervention: Let
Number of subjects: 75
Study: 35863467

Group type: EXPERIMENTAL
Intervention: Tralokinumab
Number of subjects: 1174
Study: 35419799

Group type: EXPERIMENTAL
Intervention: Sufentanil (5 μg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (1 mL normal saline)
Number of subjects: 30
Study: 33971938

Group type: EXPERIMENTAL
Intervention: Bilberry powder (active)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: High-fiber bioprocessed oat bran (active)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Bilberry and oats combined (active)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Reference beverages containing no active bilberry or active oats (control)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: All active interventions
Number of subjects: 900
Study: 33234653

Group type: EXPERIMENTAL
Intervention: STOP touching your face intervention (750-word text and 5 min audio description online)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: STOP touching your face intervention
Number of subjects: 1000
Study: 34994830

Group type: EXPERIMENTAL
Intervention: Student-centered multielement fusion teaching mode
Number of subjects: 141

Group type: COMPARATOR
Intervention: Traditional teaching method
Number of subjects: 141
Study: 33625777

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg daily
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 33046115

Group type: EXPERIMENTAL
Intervention: Breastfeeding education sessions with grandmothers' attendance
Number of subjects: 64

Group type: COMPARATOR
Intervention: Breastfeeding education sessions without grandmothers' attendance
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 64
Study: 34569489

Group type: EXPERIMENTAL
Intervention: Molidustat (25 mg once daily)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Darbepoetin (30 μg every 2 weeks)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Molidustat
Number of subjects: 162

Group type: COMPARATOR
Intervention: Darbepoetin
Number of subjects: 162
Study: 32662228

Group type: EXPERIMENTAL
Intervention: Exposure to Casuarina pollen on the day before measurement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exposure to cypress pollen 3 days prior to measurement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exposure to Pinus pollen 3 days prior to measurement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Residential greenness
Number of subjects: 0
Study: 32129202

Group type: EXPERIMENTAL
Intervention: Graded exercise training for 12 weeks
Number of subjects: 104

Group type: COMPARATOR
Intervention: Routine care for 12 weeks
Number of subjects: 104
Study: 36375329

Group type: EXPERIMENTAL
Intervention: Viloxazine extended-release (viloxazine ER, Qelbree®), flexible-dose (200-600 mg)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Data collected up to Week 2
Number of subjects: 354

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 354
Study: 32886746

Group type: EXPERIMENTAL
Intervention: 7-session modified Mindfulness-Based Cognitive Therapy (MBCT) for 10 weeks with telephone follow-up
Number of subjects: 113
Study: 32516894

Group type: EXPERIMENTAL
Intervention: RTVFD-assisted ventilation (RAV)
Number of subjects: 26
Study: 35060969

Group type: EXPERIMENTAL
Intervention: Concentrated Growth Factors (CGFs)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Demineralized Bovine Bone Matrix (DBBM)
Number of subjects: 20
Study: 32882710

Group type: EXPERIMENTAL
Intervention: Adjuvanted trivalent influenza vaccine (aTIV)
Number of subjects: 50012

Group type: COMPARATOR
Intervention: Nonadjuvanted trivalent influenza vaccine (TIV)
Number of subjects: 50012
Study: 34034337

Group type: EXPERIMENTAL
Intervention: Distraction
Number of subjects: 40

Group type: COMPARATOR
Intervention: No Distraction
Number of subjects: 40
Study: 32638970

Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise for 12 weeks
Number of subjects: 65
Study: 33094931

Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg TDS for 8 weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: Calcium tablets as placebo (control)
Number of subjects: 150
Study: 32415945

Group type: EXPERIMENTAL
Intervention: Cefotaxime combined with gamma globulins
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cefotaxime
Number of subjects: 120
Study: 35162603

Group type: EXPERIMENTAL
Intervention: Group B (aged 23 years)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Group A (aged 19 years)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Group A
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Group B
Number of subjects: 100
Study: 33985884

Group type: EXPERIMENTAL
Intervention: High-Flow Humidified Oxygen (HFHO)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 28
Study: 32103161

Group type: EXPERIMENTAL
Intervention: Donor milk programs in levels 3 and 4 neonatal care facilities
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Donor milk programs in level 2 neonatal care facilities
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Regional prevalence of donor milk programs
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Safety-net vs. non-safety-net hospitals
Number of subjects: 120
Study: 35028628

Group type: EXPERIMENTAL
Intervention: pyronaridine‐artesunate plus primaquine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: dihydroartemisinin‐piperaquine plus primaquine
Number of subjects: 100

Group type: COMPARATOR
Intervention: pyronaridine‐artesunate
Number of subjects: 100

Group type: COMPARATOR
Intervention: dihydroartemisinin‐piperaquine
Number of subjects: 100
Study: 33658605

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32560689

Group type: EXPERIMENTAL
Intervention: Personalised care and support planning (CSP)
Number of subjects: 1620

Group type: COMPARATOR
Intervention: Standard diabetes care (Control)
Number of subjects: 1620
Study: 34500485

Group type: EXPERIMENTAL
Intervention: Homeopathic remedies (Arsenicum album, Bryonia alba, Gelsemium sempervirens, Pulsatilla nigricans, Hepar sulphuricus, Magnesia muriaticum, Phosphorus, Nux vomica, Belladonna)
Number of subjects: 1445

Group type: EXPERIMENTAL
Intervention: Training of doctors, regular monitoring of data, checking of all pre-defined symptoms, multicenter data collection
Number of subjects: 1445
Study: 33487180

Group type: EXPERIMENTAL
Intervention: Endoscopic epitympanic exploration
Number of subjects: 76

Group type: COMPARATOR
Intervention: Conventional canal wall up (cortical) mastoidectomy
Number of subjects: 76
Study: 35378224

Group type: EXPERIMENTAL
Intervention: Grey-white matter differentiation (GWR) reported by radiologist
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: GWR stratified 1-year survival
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: APACHE IV score
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Cerebral Performance Categories at discharge and 90-day follow-up
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Glasgow Coma Scale at discharge
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: RAND-36 stratified by normal versus abnormal GWR
Number of subjects: 427
Study: 32842188

Group type: EXPERIMENTAL
Intervention: Pulmicort respulas immersed nasopore
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline immersed nasopore (Control)
Number of subjects: 30
Study: 34210731

Group type: EXPERIMENTAL
Intervention: Cognitive therapy for PTSD (CT-PTSD)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 120
Study: 32659874

Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (TMS) for MDD
Number of subjects: 118
Study: 35144944

Group type: EXPERIMENTAL
Intervention: Family Nurse Partnership (FNP) home-visiting programme
Number of subjects: 1618

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 1618
Study: 34529043

Group type: EXPERIMENTAL
Intervention: IABP-SHOCK II score
Number of subjects: 1055

Group type: EXPERIMENTAL
Intervention: CardShock score
Number of subjects: 1055

Group type: EXPERIMENTAL
Intervention: SAPS II score
Number of subjects: 1055

Group type: EXPERIMENTAL
Intervention: SCAI classification
Number of subjects: 1055
Study: 32735580

Group type: EXPERIMENTAL
Intervention: Reference model embedding a realistic human connectome
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomised connectome ensembles
Number of subjects: 0
Study: 35038990

Group type: EXPERIMENTAL
Intervention: Support for traditional midwives with a monthly stipend and training from an intercultural broker in intervention communities.
Number of subjects: 872

Group type: EXPERIMENTAL
Intervention: Support for traditional midwives in intervention communities.
Number of subjects: 872

Group type: EXPERIMENTAL
Intervention: Support for traditional midwives in intervention communities during institutional childbirths.
Number of subjects: 872

Group type: EXPERIMENTAL
Intervention: Support for traditional midwives in intervention communities during home-based childbirths.
Number of subjects: 872
Study: 33846503

Group type: EXPERIMENTAL
Intervention: D‐MCT (Metacognitive Training for Depression)
Number of subjects: 84

Group type: COMPARATOR
Intervention: MyBrainTraining (Cognitive Remediation Training)
Number of subjects: 84
Study: 35222584

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (group A, n=35)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Resistance exercise intervention (group B, n=35)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison between Aerobic and Resistance exercise
Number of subjects: 60
Study: 32006099

Group type: EXPERIMENTAL
Intervention: Body-weight lunges with blood-flow restriction (occlusion set at 130% of systolic blood pressure)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Body-weight lunges without blood-flow restriction
Number of subjects: 18
Study: 34961732

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 3987

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 3987
Study: 33211063

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg IV every 3 weeks) + Bevacizumab (15 mg/kg IV every 3 weeks) + Oral Cyclophosphamide (50 mg once daily)
Number of subjects: 40
Study: 35236394

Group type: EXPERIMENTAL
Intervention: Release of Wolbachia-infected Aedes aegypti mosquitoes
Number of subjects: 3480

Group type: COMPARATOR
Intervention: No release of Wolbachia-infected Aedes aegypti mosquitoes (control)
Number of subjects: 3480
Study: 33724898

Group type: EXPERIMENTAL
Intervention: Self-hypnotic relaxation (SHR) app
Number of subjects: 72

Group type: COMPARATOR
Intervention: Background audio (BA) app (Android)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Background audio (BA) app (iOS)
Number of subjects: 72
Study: 34363315

Group type: EXPERIMENTAL
Intervention: Three-dimensional printed models (3DP)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Plastinated specimens
Number of subjects: 63
Study: 34842924

Group type: EXPERIMENTAL
Intervention: CP plus ST
Number of subjects: 487

Group type: COMPARATOR
Intervention: ST alone
Number of subjects: 487
Study: 35926990

Group type: EXPERIMENTAL
Intervention: PA coaching intervention underpinned by motivational interviewing and cognitive‐behavioural therapy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: PA coaching intervention
Number of subjects: 18
Study: 34473215

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg IV 60 minutes before anesthesia)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo (2 mL IV normal saline 60 minutes before anesthesia)
Number of subjects: 192
Study: 35763437

Group type: EXPERIMENTAL
Intervention: Snail secretion filtrate, Calendula officinalis, and Glycyrrhiza glaba root extract combination serum (SCGS)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Snail secretion filtrate, Calendula officinalis, and Glycyrrhiza glaba root extract combination serum (SCGS) with concurrent acne treatments
Number of subjects: 66
Study: 35065722

Group type: EXPERIMENTAL
Intervention: Peer support plus care as usual
Number of subjects: 590

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 590
Study: 33653406

Group type: EXPERIMENTAL
Intervention: Integrated community and primary healthcare worker intervention involving an anti-stigma campaign and a mobile-technology-based electronic decision support system.
Number of subjects: 133
Study: 36154349

Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBG) 400 mg administered 15 min prior to the trial and after 5 h
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBG)
Number of subjects: 12
Study: 32130172

Group type: EXPERIMENTAL
Intervention: Mobile phone-based glucose-monitoring and feedback system
Number of subjects: 247

Group type: COMPARATOR
Intervention: Control group (standard outpatient care)
Number of subjects: 247
Study: 35618329

Group type: EXPERIMENTAL
Intervention: Upa Yoga intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Advice-only control group
Number of subjects: 0
Study: 32712683

Group type: EXPERIMENTAL
Intervention: ARIF (arthroscopic reduction and internal fixation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: ORIF (open reduction internal fixation)
Number of subjects: 40
Study: 35863812

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 24

Group type: COMPARATOR
Intervention: No therapy (Control)
Number of subjects: 24
Study: 34310725

Group type: EXPERIMENTAL
Intervention: Active Engagement (ENG)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Spaced Retrieval Practice (SRP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No Active Engagement (no ENG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No Spaced Retrieval Practice (no SRP)
Number of subjects: 120
Study: 32153301

Group type: EXPERIMENTAL
Intervention: Pleuralvent™ device
Number of subjects: 126

Group type: COMPARATOR
Intervention: Chest tube insertion (16F)
Number of subjects: 126
Study: 34669044

Group type: EXPERIMENTAL
Intervention: LIGHT session (50% of maximal knee-extension strength)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: HEAVY session (≥80% maximal knee-extension strength)
Number of subjects: 16
Study: 32794404

Group type: EXPERIMENTAL
Intervention: ASCUS (+) HPV (+) patients
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (ASCUS (−))
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: ASCUS (−) or ASCUS (+) HPV (−) patients
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: ASCUS (+) HPV (−) patients
Number of subjects: 200
Study: 32347624

Group type: EXPERIMENTAL
Intervention: Risperidone plus sulforaphane
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 36072608

Group type: EXPERIMENTAL
Intervention: FF/UMEC/VI 100/62.5/25 mcg
Number of subjects: 1810

Group type: COMPARATOR
Intervention: BUD/FOR 400/12 mcg
Number of subjects: 1810
Study: 35849886

Group type: EXPERIMENTAL
Intervention: Nurse-led medication self-management intervention
Number of subjects: 136

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 136
Study: 33724597

Group type: EXPERIMENTAL
Intervention: Novel cluster definitions and min(p) method for fMRI data analysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing fMRI analysis methods
Number of subjects: 0
Study: 32348036

Group type: EXPERIMENTAL
Intervention: Dupilumab (administered intravenously or subcutaneously)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dupilumab (various products and formulations administered as single subcutaneous doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dupilumab (administered as fast versus slow subcutaneous injections)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group in randomized, double-blind studies)
Number of subjects: 0
Study: 34717551

Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 218

Group type: COMPARATOR
Intervention: Regional anesthesia
Number of subjects: 218

Group type: COMPARATOR
Intervention: Regional anesthesia with sedation
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Increased postoperative pain intensity (measured by visual analogue scale)
Number of subjects: 218
Study: 32472880

Group type: EXPERIMENTAL
Intervention: Percutaneous Balloon Compression (PBC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Microvascular Decompression (MVD)
Number of subjects: 60
Study: 35366640

Group type: EXPERIMENTAL
Intervention: Cilobradine
Number of subjects: 367

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 367
Study: 33892117

Group type: EXPERIMENTAL
Intervention: Healicoil Regenesorb (PLGA/ß‐TCP/Calcium Sulfate)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Twinfix Ultra HA (PLLA/HA)
Number of subjects: 64
Study: 32641706

Group type: COMPARATOR
Intervention: 50 Hz tACS applied to the left cerebellum
Number of subjects: 15
Study: 35579025

Group type: EXPERIMENTAL
Intervention: True acupuncture with standard of care (SOC)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sham procedure with SOC
Number of subjects: 72

Group type: COMPARATOR
Intervention: SOC only
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 72
Study: 34670534

Group type: EXPERIMENTAL
Intervention: Open surgery followed by PRP application (Group B)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Curettage of the sinus cavity followed by application of PRP (Group C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open surgery and moist dressings (Group A)
Number of subjects: 0
Study: 32344167

Group type: EXPERIMENTAL
Intervention: Umifenovir
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control
Number of subjects: 81
Study: 35564926

Group type: EXPERIMENTAL
Intervention: app‐based ABC games
Number of subjects: 86

Group type: COMPARATOR
Intervention: Tetris
Number of subjects: 86

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 86
Study: 34250712

Group type: EXPERIMENTAL
Intervention: Combined IPL/fractional Er:YAG treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fractional Er:YAG laser treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated control sites
Number of subjects: 0
Study: 32562272

Group type: EXPERIMENTAL
Intervention: CC corn-based diet
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: BT corn-based diet
Number of subjects: 72

Group type: COMPARATOR
Intervention: CT corn-based diet
Number of subjects: 72
Study: 35775679

Group type: EXPERIMENTAL
Intervention: Medical treatment (Group M)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Appendectomy (Group A)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Medical treatment responders (Group MR)
Number of subjects: 64
Study: 32925688

Group type: EXPERIMENTAL
Intervention: Patients under age 75
Number of subjects: 88988

Group type: COMPARATOR
Intervention: Patients aged 75 and older
Number of subjects: 88988
Study: 32754804

Group type: EXPERIMENTAL
Intervention: GAD-alum immunotherapy (recombinant GAD65 conjugated to aluminium hydroxide)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36286272

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 0
Study: 32017413

Group type: EXPERIMENTAL
Intervention: Hand massage with a warm hand bath
Number of subjects: 28
Study: 35471153

Group type: EXPERIMENTAL
Intervention: Olipudase alfa
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study: 34518408

Group type: EXPERIMENTAL
Intervention: Short-form Cohen-Mansfield Agitation Inventory (CMAI)
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: Short-form CMAI
Number of subjects: 553